3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Psoriasis
1
Pruritus
1
Lymphoma, Follicular
1
Interventions
tofacitinib
5
Aprepitant
3
masitinib
2
desloratadine
1
apremilast
1
Lidocaine
1
Etanercept
1
Capsules
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Pruritus
×
apremilast
×
Clear all
NCT03721172
2024-05-29
ADVANCE
Amgen
Phase 3
Completed
595 enrolled
19 charts